Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS)

A. R. L. Medford, H. Kendall, L. Armstrong, A. B. Millar (Bristol, United Kingdom)

Source: Annual Congress 2002 - Mechanisms and markers of acute and chronic lung injury
Session: Mechanisms and markers of acute and chronic lung injury
Session type: Poster Discussion
Number: 1487
Disease area: Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. R. L. Medford, H. Kendall, L. Armstrong, A. B. Millar (Bristol, United Kingdom). Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS). Eur Respir J 2002; 20: Suppl. 38, 1487

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Frequency and significance of vascular endothelial growth factor (VEGF) 936 C/T polymorphism in acute respiratory distress syndrome (ARDS)
Source: Eur Respir J 2002; 20: Suppl. 38, 227s
Year: 2002

Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005

Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury
Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Year: 2003


A comparative study of two angiogenic factors: vascular endothelial growth factor (VEGF) and angiogenin (Ang) in induced sputum from asthmatic children in acute attack
Source: Eur Respir J 2006; 28: Suppl. 50, 258s
Year: 2006

The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018



Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006

Expression of bradykinin B2 receptor (B2R) and vascular endothelial growth factor (VEGF) in asthma and COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007

A role for vascular endothelial growth factor (VEGF) in fibrosis?
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia
Source: Eur Respir J 2001; 17: 681-687
Year: 2001



Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006

Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Regulation of vascular endothelial growth factor expression in a mouse model of acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006

Vascular endothelial growth factor (VEGF) is a predictable marker for FEV1 progression in patients with Lymphangiolyomyomatosis (LAM).
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019


Increased shedding of low density lipoprotein receptor-related protein-1 (LRP-1) in patients with acute respiratory distress syndrome (ARDS) prevents cellular clearance of matrix metalloproteinase-2 (MMP-2) and correlates with disease severity
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009


Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006

Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome
Source: Eur Respir J 2009; 33: 543-550
Year: 2009



Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005